Carbidopa suppresses estrogen receptor-positive breast cancer via AhR-mediated proteasomal degradation of ERα.
Chen Z, Xia X, Chen H, Huang H, An X, Sun M, Yao Q, Kim K, Zhang H, Chu M, Chen R, Bhutia YD, Ganapathy V, Kou L.
Chen Z, et al. Among authors: zhang h.
Invest New Drugs. 2022 Dec;40(6):1216-1230. doi: 10.1007/s10637-022-01289-5. Epub 2022 Sep 7.
Invest New Drugs. 2022.
PMID: 36070108